No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM webcast 9/12/2018
8
Sep 10, 2018 05:56PM

I echo Bears thanks to those attending the AGMs. The note have been invaluable.

GLTA

Toinv

4
bfw
Sep 12, 2018 04:50PM
5
Sep 12, 2018 07:29PM
Share
New Message
Please login to post a reply